Shopping Cart 0
Cart Subtotal
USD 0

Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Cipla Ltd (CIPLA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, malaria, cancer, neurological, ophthalmic, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.

Cipla Ltd Key Recent Developments

Jun 21,2019: Cipla: Resignation of Mr. Peter Lankau as Independent Director of the Company

Jun 10,2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility

May 22,2019: Cipla reports Q4 and FY19 results

May 17,2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility

Apr 22,2019: Cipla names Dr. Raju Mistry as Global Chief People Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Cipla Ltd-Key Facts

Cipla Ltd-Key Employees

Cipla Ltd-Key Employee Biographies

Cipla Ltd-Major Products and Services

Cipla Ltd-History

Cipla Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Cipla Ltd-Business Description

Business Segment: New Ventures

Overview

Performance

Business Segment: Pharmaceuticals

Overview

Performance

R&D Overview

Cipla Ltd-Corporate Strategy

Cipla Ltd-SWOT Analysis

SWOT Analysis-Overview

Cipla Ltd-Strengths

Cipla Ltd-Weaknesses

Cipla Ltd-Opportunities

Cipla Ltd-Threats

Cipla Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Power Financial Deals and Alliances

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cipla Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 21, 2019: Cipla: Resignation of Mr. Peter Lankau as Independent Director of the Company

Jun 10, 2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility

May 22, 2019: Cipla reports Q4 and FY19 results

May 17, 2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility

Apr 22, 2019: Cipla names Dr. Raju Mistry as Global Chief People Officer

Apr 17, 2019: Pulmatrix and Cipla collaborate to develop asthma drug

Mar 31, 2019: Cipla: Product specific pre-approval (PAI) and Good Manufacturing Practices (GMP) inspection at its Kurkumbh plant

Feb 18, 2019: Cipla and Wellthy Therapeutics announce partnership to offer digital therapeutics for diabetes and cardiovascular diseases

Oct 04, 2018: Cipla:Inspection by the United States Food and Drug Administration (USFDA) at the Goa manufacturing facility

Sep 10, 2018: Understanding depression and related symptoms key to suicide prevention in SA

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cipla Ltd, Performance Chart (2015-2019)

Cipla Ltd, Ratio Charts

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Cipla Ltd, Key Facts

Cipla Ltd, Key Employees

Cipla Ltd, Key Employee Biographies

Cipla Ltd, Major Products and Services

Cipla Ltd, History

Cipla Ltd, Subsidiaries

Cipla Ltd, Key Competitors

Cipla Ltd, Ratios based on current share price

Cipla Ltd, Annual Ratios

Cipla Ltd, Annual Ratios (Cont...1)

Cipla Ltd, Annual Ratios (Cont...2)

Cipla Ltd, Interim Ratios

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cipla Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Cipla Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Alembic Limited

Dr. Reddy's Laboratories Ltd

Lupin Ltd

Aurobindo Pharma Ltd

Sun Pharmaceutical Industries Ltd

Biocon Ltd

Cadila Healthcare Ltd

Torrent Pharmaceuticals Ltd

Cipla Ltd (CIPLA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, malaria, cancer, neurological, ophthalmic, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.

Cipla Ltd Key Recent Developments

Jun 21,2019: Cipla: Resignation of Mr. Peter Lankau as Independent Director of the Company

Jun 10,2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility

May 22,2019: Cipla reports Q4 and FY19 results

May 17,2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility

Apr 22,2019: Cipla names Dr. Raju Mistry as Global Chief People Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Cipla Ltd-Key Facts

Cipla Ltd-Key Employees

Cipla Ltd-Key Employee Biographies

Cipla Ltd-Major Products and Services

Cipla Ltd-History

Cipla Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Cipla Ltd-Business Description

Business Segment: New Ventures

Overview

Performance

Business Segment: Pharmaceuticals

Overview

Performance

R&D Overview

Cipla Ltd-Corporate Strategy

Cipla Ltd-SWOT Analysis

SWOT Analysis-Overview

Cipla Ltd-Strengths

Cipla Ltd-Weaknesses

Cipla Ltd-Opportunities

Cipla Ltd-Threats

Cipla Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Power Financial Deals and Alliances

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cipla Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 21, 2019: Cipla: Resignation of Mr. Peter Lankau as Independent Director of the Company

Jun 10, 2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility

May 22, 2019: Cipla reports Q4 and FY19 results

May 17, 2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility

Apr 22, 2019: Cipla names Dr. Raju Mistry as Global Chief People Officer

Apr 17, 2019: Pulmatrix and Cipla collaborate to develop asthma drug

Mar 31, 2019: Cipla: Product specific pre-approval (PAI) and Good Manufacturing Practices (GMP) inspection at its Kurkumbh plant

Feb 18, 2019: Cipla and Wellthy Therapeutics announce partnership to offer digital therapeutics for diabetes and cardiovascular diseases

Oct 04, 2018: Cipla:Inspection by the United States Food and Drug Administration (USFDA) at the Goa manufacturing facility

Sep 10, 2018: Understanding depression and related symptoms key to suicide prevention in SA

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cipla Ltd, Performance Chart (2015-2019)

Cipla Ltd, Ratio Charts

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Cipla Ltd, Key Facts

Cipla Ltd, Key Employees

Cipla Ltd, Key Employee Biographies

Cipla Ltd, Major Products and Services

Cipla Ltd, History

Cipla Ltd, Subsidiaries

Cipla Ltd, Key Competitors

Cipla Ltd, Ratios based on current share price

Cipla Ltd, Annual Ratios

Cipla Ltd, Annual Ratios (Cont...1)

Cipla Ltd, Annual Ratios (Cont...2)

Cipla Ltd, Interim Ratios

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cipla Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Cipla Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Alembic Limited

Dr. Reddy's Laboratories Ltd

Lupin Ltd

Aurobindo Pharma Ltd

Sun Pharmaceutical Industries Ltd

Biocon Ltd

Cadila Healthcare Ltd

Torrent Pharmaceuticals Ltd

chat_bubbleLet's Chat